Latest News about GILD
Recent news which mentions GILD
From InvestorPlace
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia Settings
February 09, 2023
Tickers
GILD
From Benzinga
2 Biotech Stocks That Could Make You Richer
February 09, 2023
From Motley Fool
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
From Motley Fool
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
February 03, 2023
Tickers
GILD
From Benzinga
'Risk Of Overheating': 4 Experts On Hot January Jobs Report, How The Fed Will React
February 03, 2023
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
Tickers
GILD
From Motley Fool
Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript
February 02, 2023
Tickers
GILD
From Motley Fool
Why Gilead Sciences Stock Is Trading Higher After Hours
February 02, 2023
Tickers
GILD
From Benzinga
This trader nailed two big market calls in 2022. She says investors are ‘being paid to wait’ so should steer clear of stocks for 2023.
February 02, 2023
From MarketWatch
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
February 02, 2023
From Benzinga
From Benzinga
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
Could Gilead Sciences Stock Help You Become a Millionaire?
January 26, 2023
Tickers
GILD
From Motley Fool
3 Smart Stocks to Buy if a Recession Is on the Way
January 21, 2023
From Motley Fool
3 Stocks That Beat the S&P During the Great Recession
January 18, 2023
From Motley Fool
2 Unstoppable Stocks That Could Beat the Market Again In 2023
January 11, 2023
From Motley Fool
XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave
January 06, 2023
From MarketWatch
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
From Motley Fool
From Benzinga
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
December 30, 2022
From Benzinga
This New Drug Could Be Gilead Sciences' Growth Catalyst
December 29, 2022
Tickers
GILD
From Motley Fool
3 High-Yielding Dividend Stocks That Could See Hikes in January
December 29, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.